619 related articles for article (PubMed ID: 31184599)
1. Targetable mechanisms driving immunoevasion of persistent senescent cells link chemotherapy-resistant cancer to aging.
Muñoz DP; Yannone SM; Daemen A; Sun Y; Vakar-Lopez F; Kawahara M; Freund AM; Rodier F; Wu JD; Desprez PY; Raulet DH; Nelson PS; van 't Veer LJ; Campisi J; Coppé JP
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31184599
[TBL] [Abstract][Full Text] [Related]
2. NKG2D ligands mediate immunosurveillance of senescent cells.
Sagiv A; Burton DG; Moshayev Z; Vadai E; Wensveen F; Ben-Dor S; Golani O; Polic B; Krizhanovsky V
Aging (Albany NY); 2016 Feb; 8(2):328-44. PubMed ID: 26878797
[TBL] [Abstract][Full Text] [Related]
3. Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity.
Inao T; Kotani H; Iida Y; Kartika ID; Okimoto T; Tanino R; Shiba E; Harada M
Cancer Sci; 2019 Sep; 110(9):2690-2699. PubMed ID: 31250942
[TBL] [Abstract][Full Text] [Related]
4. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment.
Jeon OH; Kim C; Laberge RM; Demaria M; Rathod S; Vasserot AP; Chung JW; Kim DH; Poon Y; David N; Baker DJ; van Deursen JM; Campisi J; Elisseeff JH
Nat Med; 2017 Jun; 23(6):775-781. PubMed ID: 28436958
[TBL] [Abstract][Full Text] [Related]
5. Cellular senescence as a possible link between prostate diseases of the ageing male.
Fiard G; Stavrinides V; Chambers ES; Heavey S; Freeman A; Ball R; Akbar AN; Emberton M
Nat Rev Urol; 2021 Oct; 18(10):597-610. PubMed ID: 34294916
[TBL] [Abstract][Full Text] [Related]
6. Flightless I Homolog Reverses Enzalutamide Resistance through PD-L1-Mediated Immune Evasion in Prostate Cancer.
Ruan H; Bao L; Tao Z; Chen K
Cancer Immunol Res; 2021 Jul; 9(7):838-852. PubMed ID: 34011528
[TBL] [Abstract][Full Text] [Related]
7. Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.
Mamessier E; Sylvain A; Bertucci F; Castellano R; Finetti P; Houvenaeghel G; Charaffe-Jaufret E; Birnbaum D; Moretta A; Olive D
Cancer Res; 2011 Nov; 71(21):6621-32. PubMed ID: 21937679
[TBL] [Abstract][Full Text] [Related]
8. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
9. Natural killer group 2D receptor and its ligands in cancer immune escape.
Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
[TBL] [Abstract][Full Text] [Related]
10. NKG2D-CAR T cells eliminate senescent cells in aged mice and nonhuman primates.
Yang D; Sun B; Li S; Wei W; Liu X; Cui X; Zhang X; Liu N; Yan L; Deng Y; Zhao X
Sci Transl Med; 2023 Aug; 15(709):eadd1951. PubMed ID: 37585504
[TBL] [Abstract][Full Text] [Related]
11. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.
Coppé JP; Patil CK; Rodier F; Sun Y; Muñoz DP; Goldstein J; Nelson PS; Desprez PY; Campisi J
PLoS Biol; 2008 Dec; 6(12):2853-68. PubMed ID: 19053174
[TBL] [Abstract][Full Text] [Related]
12. Taxanes enhance trastuzumab-mediated ADCC on tumor cells through NKG2D-mediated NK cell recognition.
Di Modica M; Sfondrini L; Regondi V; Varchetta S; Oliviero B; Mariani G; Bianchi GV; Generali D; Balsari A; Triulzi T; Tagliabue E
Oncotarget; 2016 Jan; 7(1):255-65. PubMed ID: 26595802
[TBL] [Abstract][Full Text] [Related]
13. Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse.
Demaria M; O'Leary MN; Chang J; Shao L; Liu S; Alimirah F; Koenig K; Le C; Mitin N; Deal AM; Alston S; Academia EC; Kilmarx S; Valdovinos A; Wang B; de Bruin A; Kennedy BK; Melov S; Zhou D; Sharpless NE; Muss H; Campisi J
Cancer Discov; 2017 Feb; 7(2):165-176. PubMed ID: 27979832
[TBL] [Abstract][Full Text] [Related]
14. NKG2D Ligand Shedding in Response to Stress: Role of ADAM10.
Zingoni A; Vulpis E; Loconte L; Santoni A
Front Immunol; 2020; 11():447. PubMed ID: 32269567
[TBL] [Abstract][Full Text] [Related]
15. Reactive oxygen species- and DNA damage response-dependent NK cell activating ligand upregulation occurs at transcriptional levels and requires the transcriptional factor E2F1.
Soriani A; Iannitto ML; Ricci B; Fionda C; Malgarini G; Morrone S; Peruzzi G; Ricciardi MR; Petrucci MT; Cippitelli M; Santoni A
J Immunol; 2014 Jul; 193(2):950-60. PubMed ID: 24913980
[TBL] [Abstract][Full Text] [Related]
16. Stressing the cell cycle in senescence and aging.
Chandler H; Peters G
Curr Opin Cell Biol; 2013 Dec; 25(6):765-71. PubMed ID: 23916530
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell recognition by the NK cell activating receptor NKG2D.
Bryceson YT; Ljunggren HG
Eur J Immunol; 2008 Nov; 38(11):2957-61. PubMed ID: 18979516
[TBL] [Abstract][Full Text] [Related]
18. Impairment of NKG2D-Mediated Tumor Immunity by TGF-β.
Lazarova M; Steinle A
Front Immunol; 2019; 10():2689. PubMed ID: 31803194
[TBL] [Abstract][Full Text] [Related]
19. p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells.
Iannello A; Thompson TW; Ardolino M; Lowe SW; Raulet DH
J Exp Med; 2013 Sep; 210(10):2057-69. PubMed ID: 24043758
[TBL] [Abstract][Full Text] [Related]
20. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity.
Toso A; Revandkar A; Di Mitri D; Guccini I; Proietti M; Sarti M; Pinton S; Zhang J; Kalathur M; Civenni G; Jarrossay D; Montani E; Marini C; Garcia-Escudero R; Scanziani E; Grassi F; Pandolfi PP; Catapano CV; Alimonti A
Cell Rep; 2014 Oct; 9(1):75-89. PubMed ID: 25263564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
